← Leaderboards
Petra Popovics
Eastern Virginia Medical School
$1,531,371
Attributed
$1,531,371
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $594.1K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,531,371 · 2
By mechanism
R01$901,540 · 1
K01$629,831 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Osteopontin”
- Gregory Scott Day · Washington University$4,080,222
- Maarten Hulsmans · Massachusetts General Hospital$2,892,041
- Temugin Berta · University Of Cincinnati$2,103,564
- Taben M. Hale · University Of Arizona$1,939,780
- Maria L Padilla · National Jewish Health$1,636,630
- Y. Alan Wang · University Of Tx Md Anderson Can Ctr$1,445,804
Research focus
OsteopontinQuality Of LifeInflammatoryMolecular TargetPathway InteractionsProstatic DiseasesFibrosisInflammationMaleMolecularPathologyAgingProstateProstaticCytokineEnvironmentFunctional DisorderImmuneKnockout MiceLower Urinary Tract SymptomsMedicalChemokineBenignSecondary To
Grant awards (9)
Identifying the role of lipid accumulation and foam cells in benign prostate disease$452,707
R01 · FY2025 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$63,113
K01 · FY2025 · DK · contact PI
Identifying the role of lipid accumulation and foam cells in benign prostate disease$448,833
R01 · FY2024 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$95,240
K01 · FY2024 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$49,989
K01 · FY2024 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$145,229
K01 · FY2023 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$72,040
K01 · FY2022 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$65,340
K01 · FY2022 · DK · contact PI
Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis$138,880
K01 · FY2021 · DK · contact PI